Endocannabinoid system and trpv1 receptors in the dorsal hippocampus of the rats modulate anxiety-like behaviors
Reports of Biochemistry & Molecular Biology
Vol. 3, No. 2, Apr 2015
Short article
Pattern of Infection and Antibiotic Activity among
Streptococcus agalactiae Isolates from Adults
in Mashhad, Iran
Masoumeh Malek-Jafarian1, Fatemeh-Sadat Hosseini*1,
Abodol-Reza Ahmadi1
Abstract
Background: One of the main causes of sexually transmitted diseases is
group B β- hemolytic
streptococci (GBS) multiplying in the genital tracts. Penicillin is the most common drug for the
treatment of infections caused by these bacteria, but in patients suffering from Penicillin allergy,
Erythromycin and Clindamycin are used as alternative therapeutic drugs against GBS. Recently,
resistance to these drugs has been reported more often. In this study, efforts have been made to
determine the prevalence and antibiotic resistance of GBS.
Methods: Modified Christie Atkins Munch-Petersen (CAMP) test was conducted on over 2400
samples of urine and discharge taken from vagina, urethra and prostate. The drug sensitivity was
performed by double disk sensitivity tests to Bacitracin, Trimethoprim, and Sulfamethoxazole and
then the resistant samples were investigated by E-test to determine the minimal inhibitory
concentrations (MICs) value.
Results: Twenty-three vaginal and 10 urethral discharge, 27urine and 6 prostatic secretion samples
were GBS positive. The most symbiotic microorganisms with GBS were strains of
Enterococci (90%),
Staphylococcus saprophyticus (25%) and
Candida albicans (6%). The disk diffusion
method showed 18 cases with Penicillin resistance (MIC: 1.5 mg/ml).
Conclusion: Taken together, GBS carriers' rate in this study was found 20.65% (8.24% men and
12.4% women). Furthermore, findings showed high-level resistance to Erythromycin and
Clindamycin.
Keywords: Antibiotic resistance, Genitourinary system, Minimal inhibitory concentration (MIC),
Streptococcus agalactiae,
Introduction
Group B β- hemolytic streptococci (GBS) is the main
in adults. Especially people with background diseases
cause of blood infection and Meningitis in infants (1,
such as diabetes mellitus, malignant tumor, liver and
2). According to the statistics published by the World
kidney failure, immune deficiency such as acquired
Health Organization (WHO), about 15-45% of
immunodeficiency syndrome (AIDS) are at the risk
women are affected by GBS in their genitourinary
for GBS (6-9). Moreover, GBS increases the risk for
system (3, 4). Fifty percent of infants become infected
sexual diseases; it can multiply in the male
before birth or during delivery. In such cases, nearly
reproductive organs, particularly the urethra and
1-2% of newborns will develop progressively severe
prostate and then possibly lead to pneumonia and
complications such as meningitis (5). In addition,
bacteremia (9). Penicillin is the well-known drug in
Streptococcus agalactiae may cause severe infections
the treatment of infections caused by GBS. However,
1: Department of Laboratory Medicine, School of Paramedicine, Mashhad University of Medical Sciences, Mashhad, Iran
*Corresponding author: Fatemeh-Sadat Hosseini; Tel: +98 51- 38827029; Fax: +98- 51- 37684082; E-mail: [email protected]
Received: Jun 21, 2014; Accepted: Oct 10, 2014
Malek-Jafarian M et al.
for people who have an allergic reaction to Penicillin,
by antibiotic carriers were applied to each plate. After
Erythromycin and Clindamycin are prescribed for
overnight incubation, the MIC was reported at the
patients with GBS infections. Recently, a developing
intersection of growth inhibition zone with the strip.
resistance to these drugs has been reported (10). The
purpose of this study was to determine the prevalence
of
S. agalactiae in genitourinary system infections
Table 1 shows the frequent GBS infections by gender
and its resistance to Erythromycin and Clindamycin.
representing 69.7% of women carrying GBS.
Clinical isolates from different sites distributed
Materials and Methods
among different age groups are summarized in table
Samples were obtained from individuals with the
2. With routine identification tests, a total of 66 GBS
genitourinary system infection (aged 15-40 and over)
isolates were characterized (27 Urine, 23 Vagina, 9
referred to medical diagnostic laboratories in
Urethra and 6 Prostate). The majority were from the
Mashhad (Iran). Human specimens for testing
collected samples of urine and vaginal discharge
included urine (n=1687), discharge taken from the
demonstrating 40.9% and 34.85%, respectively.
vagina (n=208), urethra (n=200) and prostate
Moreover, our findings indicated that specimens
(n=205). At first, epithelial cells (ECs) and white
taken from the vagina were more infected with GBS
blood cells (WBCs) were counted for all samples.
in 26-35 years old (48%). Highest rate of GBS
Then, they were streaked over blood agar plates (5%
presence in urinary tract was reported among
sheep's blood) and incubated into a candle jar. The
individuals over 40 years old (67%). For urethra and
symbiotic relationship with
Enterococcus,
prostate secretion, this was ranged from 31 to 40
Staphylococcus saprophyticus and
Candida albicans
years old (40%). As shown in table 2, there was an
(11), and the GBS identification from clinical
abnormal increase in the number of WBCs and ECs
specimens were analyzed using bacitracin, catalase,
in about 34% of GBS isolates.
CAMP and Gram stain tests (12, 13). Moreover,
It was observed that the most symbiotic
subsequent tests were performed to estimate different
interactions were occurring between GBS and
resistance levels of GBS to different antibiotics
Enterococcus, 90%, followed by
Staphylococcus
(Ampicillin, Penicillin, Clindamycin, Erythromycin,
saprophyticus, 25.7% (Table 3).
Amoxiclav, Ceftriaxone, Vancomycin, Amikacin,
Gentamicin, Nalidixic acid and Kanamycin).
frequencies with Trimethoprim and Sulfamethoxazole.
Clinical isolates of GBS on blood agar were
About 27% of infectious samples were resistant to
suspended in standard saline inoculating on Mueller-
Penicillin at MIC of 1.5 µg/ml. The percentage of
Hinton agar plates. Then, two prepared disks of
GBS resistance to Clindamycin and Erythromycin
Trimethoprim and Sulfamethoxazole (Masc Co, UK)
were 20% and 24.5%, respectively, with the average
were placed on the plates and incubated overnight
MIC value of 0.01 µg/ml. Furthermore, the disk
diffusion susceptibility to Amikacin, Gentamicin,
In parallel, minimal inhibitory concentration (MIC)
Nalidixic acid and Kanamycin resulted in 100%
values were measured by E-test method and
resistance for all clinical isolates of GBS fully
interpreted as susceptible, intermediate or resistant
(15). As described for disk diffusion, the inoculation
was carried out in the plates, and then strips covered
Table 1. The percentage of GBS carriers by gender.
Total patients
GBS carrier
90 Rep. Biochem. Mol. Biol, Vol. 3, No. 2, Apr 2015
Infection and Antibiotic Activity Among Streptococcus agalactiae Isolates
Table 2. Cell counts in obtained specimens and on site distributions among different age groups
Prostate
Variable
White blood cells
Epithelial cells
Table 3. The culture positivity rate of Group β- hemolytic streptococci (GBS) and its coexistence organisms.
Enterococcus specie
Staphylococcus aureus
Candida species
Table 4. Sensitivity testing frequencies with Trimethoprim and Sulfamethoxazole.
Antibiotic
Susceptible ( %)
Intermediate (%)
Resistant (%)
Ampicillin
Penicillin
Clindamycin
Amoxiclav
Ceftriaxone
Vancomycin
Amikacin
Gentamicin
Nalidixic acid
Kanamycin
Rep. Biochem. Mol. Biol, Vol. 3, No. 2, Apr 2015
Malek-Jafarian M et al.
Discussion
A growing body of literature reported that the
resistance rate of GBS to Clindamycin and
infection rate and the frequency of antibiotic
Erythromycin were among ranges (4-43% for
resistance of GBS have increased in adults (16).
Clindamycin and 1.7-46% for Erythromycin) so far
Taking into account all studies to date, these different
recorded (16). We detected lower resistant rate to
incidence rates well correlated with geography, age,
Clindamycin than those to Penicillin and
gender and collection sites reveal serious reservations
Erythromycin. Besides, GBS isolates showed full
about performing the susceptibility test before
susceptibility against Ceftriaxone providing another
prescribing any antibiotic therapy (17).
alternative option for treating patients especially
To elucidate the frequent sites in various age and
women with a penicillin allergy in our environment
gender groups and resistance rate of GBS, 2400
samples from clinical laboratories in Mashhad, Iran,
Our results highlight a rapid screening method
were studied and patterns of the antibiotic activity
for diagnosing GBS in women. In addition,
were carried out by the disk diffusion susceptibility.
Clindamycin and Ceftriaxone are suggested as
Of the 2400 specimens, vagina indicated a
alternative antibacterial against GBS.
higher proportion of GBS infection (11.05%)
among the rest of isolates. In previous studies the
frequency of GBS collection from different sites has
The authors would like to thank Ms. Motahare Sadat
also predominated in vaginal swabs (15, 18, 19).
Hosseini at Varastegan Institute for Medical Sciences
Surprisingly comparison of our findings with
(Mashhad, Iran) for her kind help improving the
those from Iran or other countries disclosed that the
References
1. Wang JT, Hsueh PR, Sheng WH, Chang SC,
Illinois: American Academy of Pediatrics; 2012. p.
Luh KT. Infected chylothorax caused by
Streptococcus agalactiae: a case report.J Formos Med
6. Tunkel AR. Bacterial meningitis. Philadelphia:
Assoc. 2000 Oct;99(10): 783-4.
Lippincott Williams & Wilkins; 2001.
2. Andersen JR, Christensen R, Hertel J. Clinical
7. Schuchat A. Epidemiology of group B
features and epidemiology of septicaemia and
streptococcal disease in the United States: shifting
meningitis in neonates due to
Streptococcus agalactiae
paradigms. Clin Microbiol Rev. 1998 Jul; 11(3):497-
in Copenhagen County, Denmark: a 10 year survey
from 1992 to 2001. Acta Paediatr. 2004 Oct; 93(10):
8. Domingo P, Barquet N, Alvarez M, Coll P, Nava
J, Garau J. Group B streptococcal meningitis in
3. Picard FJ, Bergeron MG. Laboratory detection of
adults: report of twelve cases and review. Clin Infect
group B Streptococcus for prevention of perinatal
Dis. 1997 Nov; 25(5):1180-7.
disease. Eur J Clin Microbiol Infect Dis. 2004
9. Frey MN, Ioppi AE, Bonamigo RR, Prado GP.
Sep;23(9): 665-71.
Streptococcus agalactie involved in the etiology of
4. Foxman B, Gillespie B, Manning SD, Howard LJ,
Sexually Transmitted Diseases. An Bras Dermatol.
Tallman P, Zhang L, et al. Incidence and duration of
2011 Nov-Dec; 86 (6): 1205-7.
group B Streptococcus by serotype among male and
10. Schoening TE, Wagner J, Arvand M. Prevalence
female college students living in a single dormitory. Am
of erythromycin and clindamycin resistance among
J Epidemiol. 2006 Mar; 163(6): 544-51.
Streptococcus agalactiae isolates in Germany. Clin
5. American Academy of Pediatrics. Group B
Microbiol Infect. 2005 Jul; 11(7): 579-82.
streptococcal infections. In: Pickering LK, editors.
11. Manuel FR, MacDonald SW, Embil JA.
Red Book: 2012 Report of the Committee on
Prevalence of group B beta-hemolytic streptococci in
Infectious Diseases. 29th ed. Elk Grove Village,
the male urethra. Scand J Infect Dis. 1980; 12(1): 33-5.
92 Rep. Biochem. Mol. Biol, Vol. 3, No. 2, Apr 2015
Infection and Antibiotic Activity Among Streptococcus agalactiae Isolates
12. Darling CL. Standardization and evaluation of
Luh KT. High incidence of erythromycin resistance
the CAMP reaction for the prompt, presumptive
among clinical isolates of
Streptococcus agalactiae in
identification of
Streptococcus agalactiae (Lancefield
Taiwan. Antimicrob Agents Chemother. 2001 Nov;
group B) in clinical material. J Clin Microbiol. 1975
Feb; 1(2): 171-4.
17. Rahbar M, Hajia M, Mohammadzadeh M.
13. Yajko DM, Lawrence J, Nassos P, Young J,
Urinary tract infections caused by group b
Hadley WK. Clinical trial comparing bacitracin with
streptococcus in adult women: survey of 11800 urine
strep-A-chek for accuracy and turnaround time in the
culture results. Iran J Pathol. 2012 Jun; 7(1): 32–7.
18. Hicks P, Diaz-Perez MJ. Patient self-collection of
pyogenes. J Clin Microbiol. 1986 Sep; 24(3): 431-4.
group B streptococcal specimens during pregnancy. J
14. Grace ME, Bushby SR, Sigel CW. Diffusion of
Am Board Fam Med. 2009 Mar-Apr; 22(2): 136-40.
sulfamethoxazole
19. El-Kersh TA, Al-Nuaim LA, Kharfy TA, Al-
susceptibility disks into agar medium. Antimicrob
Shammary FJ, Al-Saleh SS, Al-Zamel FA. Detection
Agents Chemother. 1975 Jul; 8(1): 45-9.
of genital colonization of group B streptococci during
15. Al-Sweih N, Jamal M, Kurdia M,
late pregnancy. Saudi Med J. 2002 Jan; 23(1): 56-61.
20. Jannati E, Roshani M, Arzanlou M, Habibzadeh
susceptibility profile of group B streptococcus
S, Rahimi G, Shapuri R, Capsular serotype and
(Streptococcus agalactiae) at the Maternity
antibiotic resistance of group B streptococci isolated
Hospital, Kuwait. Med Princ Pract. 2005 Jul-
from pregnant women in Ardabil, Iran. Iran J
Aug;14(4):260-3.
Microbiol. 2012 Sep; 4(3): 130-5.
16. Hsueh PR, Teng LJ, Lee LN, Ho SW, Yang PC,
Rep. Biochem. Mol. Biol, Vol. 3, No. 2, Apr 2015
Source: http://www.rbmb.net/attachments/article/188/Vol.3%20No.2%20Art.7.pdf
Información de apoyo a Profesionales Agosto 2006 Revisado Enero 2010 Comentario Si bien la prevalencia de la epilepsia activa puede situarse entre el 5 – 10 / 1.000, en nuestra población de personas con P.C.I., especialmente en los cuadros más severos, esta proporción es muy superior. Las crisis aparecen, por regla general, en el primer año de vida y es habitual que mantengan una frecuencia mayor o menor de episodios críticos a lo largo de su vida y que, por tanto, estén medicados de manera permanente. No podemos olvidar que estamos hablando de personas con muchos trastornos asociados y con deterioro progresivo de su estado de salud. Por tanto, si tenemos que emplear medicación antiepiléptica, debemos considerar, muy especialmente en estos casos, la conveniencia de:
Clinical Summary Name: Justine D'Italia Date of Birth: 01/12/1964 Chief Complaint/Identifying Information: Ms. D'Italia is a 45-50 year-old woman with frequent falls with stiffening of her body, easy startling, and gait disturbance since her 20's. She is seeking Best Doctors opinion re the etiology of her symptoms and recommendations for treatment options. History of Present Illness: Ms. D'Italia is a 45-50 year old woman with seropositive rheumatoid arthritis diagnosed in 2005. She was treated with steroids initially. She is currently on Hydroxychloroquine and Methotrexate. She was diagnosed with right peroneal tenosynovitis in 2009 and underwent debridement in November 2010. She has been using a walker since the surgery. She was found to have left peroneal tendonitis in 2012. She recently started Isoniazid therapy for latent tuberculosis (equivocal PPD and positive Quantiferon gold testing). She reports she has multiple family members, including aunts and cousins, with similar symptoms to the ones she describes below. One aunt has been diagnosed with hyperekplexia. Evidently some of her family members have been treated with anti-seizure medications, but these have not been helpful. (Of note, the available neurology notes do not include this family history.) Ms. D'Italia reports the following history re her falls and gait disturbance: (There are no records available until 2006.) She reports in her 20's, she began to fall frequently. There was no prodrome before falls. She always wore high heels, and she assumed the falls were due to clumsiness. An MRI (NOS) performed in her 20's was a normal study. She was treated with Valproic Acid and then Carbamazepine. She continued to fall. At times, the falls would results in lacerations and concussions. Imaging continued to be negative. She developed a panic disorder because she never knew when she was about to fall. She became afraid to walk. She also reports that she became quite sensitive to environmental stimuli and was easily startled. Whenever she became startled, she would start to fall. She was admitted to the hospital for 4 days for continuous EEG monitoring. She was told that she did not have epilepsy, but ant-epileptic drugs were not discontinued at that time. She was seen at a different neurology clinic in approximately 2006. 48-hour ambulatory EEG monitoring was within normal limits. There were four events on the log which had no EEG correlate. She was started on Lamotrigine to treat a possible seizure disorder at some point with some benefit for a few years. In July 2009, Ms. D'Italia fell after tripping over some clutter on the floor. She hit her head against the arm of a chair and on the tile floor. She did not lose consciousness. She developed nausea and a severe headache at that time. She presented to 3 ED's over the